Detailed Analysis of Financial Performance and Strategic Initiatives
VANCOUVER, British Columbia, May 07, 2024--AbCellera Reports Q1 2024 Business Results
Quite a few insiders have dramatically grown their holdings in AbCellera Biologics Inc. ( NASDAQ:ABCL ) over the past...